From: Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer
Topotecan (mg/m2)
Vinorelbine (mg/m2)
Level 1
2
20
Level 2
2.5
Level 3
3
Level 4
3.5
Level 5
4.0